Klobuchar Michael A — SEC Form 4 filings
SEC reporting owner CIK 1871957. 8 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-24 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REVVITY, INC. (RVTY) | Director | 4 | — | — | 8 |
| Merck & Co., Inc. (MRK) | EVP - Chief Strategy Officer | 3 | — | — | 5 |
| Eikon Therapeutics, Inc. (EIKN) | Chief Operating Officer | 1 | — | — | 1 |
Form 4 filings — Klobuchar Michael A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 1,015 @ $0 · Grant/award (A): 1,265 @ $0 | EDGAR |
| 2026-03-04 | 4 | Eikon Therapeutics, Inc. (EIKN) | Grant/award (A): 87,157 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 1,074 @ $0 · Grant/award (A): 1,338 @ $0 | EDGAR |
| 2024-05-06 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 887 @ $127.51 · Tax withholding (F): 437 @ $127.51 · Option exercise (M): 887 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 977 @ $0 · Grant/award (A): 1,218 @ $0 | EDGAR |
| 2024-05-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 20,508 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | REVVITY, INC. (RVTY) | Grant/award (A): 217 @ $0 · Grant/award (A): 264 @ $0 | EDGAR |
| 2024-01-24 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 3,896 @ $119.43 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871957 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →